Research News
Share:
ByJames T. Rosenbaum, MD

Medications to Treat or Prevent COVID-19

Vaccination remains the first line of defense against COVID-19 for those who live with spondyloarthritis (SpA)...

Read more
BySpondylitis Association of America

SPARTAN Conference Spotlights the Latest Spondyloarthritis Research

Meeting in person for the first time since the start of the pandemic, the 2022 SPARTAN conference featured…

Read more
BySpondylitis Association of America

Oral JAK Inhibitor Upadacitinib (Rinvoq) Approved for Ankylosing Spondylitis

Upadacitinib is approved for the treatment of adults with active AS who…

Read more
BySpondylitis Association of America

Dietary Fiber Linked to Lower Inflammation; One Source Outshines Others

In a study led by researchers at Columbia University Mailman School of…

Read more
BySpondylitis Association of America

Biosimilars: What Are They, and What’s Coming Down the Pipeline?

The subclass of medications called biosimilars has been getting increased…

Read more
ByPatricia Remalante-Rayco, MD & Nigil Haroon, MD, PhD

Spot the Signs: Non-Radiographic Axial Spondyloarthritis

Not all people with axSpA, despite having the same inflammation and symptoms…

Read more
1 2 3 4 18